Underlying NIDCR’s Financial Management Plan is the Institute’s goal to provide stable levels of support for high quality scientific research and research training.
NIDCR is currently operating under the Further Additional Continuing Appropriations and Other Extensions Act, 2024 (Public Law 118-35) signed by President Biden on January 19, 2024. This Act, also called a Continuing Resolution (CR), continues government operations through March 8, 2024, at the Fiscal Year (FY) 2023 enacted level, with no reduction.
FY 2024 Competing Policy
NIDCR will continue to provide individual consideration to all competing applications. For all competing modular R01 and R01 equivalent applications selected for funding, NIDCR intends to reduce applications by at least 9 percent below the peer review recommended level of support. For all competing non-modular R01 and R01 equivalent applications selected for funding, NIDCR intends to reduce applications by at least 15 percent below the peer review recommended level of support. For well-funded NIDCR investigators, additional reductions may be considered.
All research project grant (RPG) applications submitted on or after January 25, 2023, competing renewal (Type 2) applications are expected to be limited to no more than a 20 percent budget increase over the last non-competing award.
For all competing research training and career development award applications selected for funding, NIDCR intends to continue providing funding at the NIDCR specific allowable costs and/or the peer review recommended level of support.
FY 2024 Non-Competing Policy
Consistent with NIH policy (NOT-OD-24-039), NIDCR will fund non-competing continuation research grant awards at 90 percent of the previous commitment level indicated on the most recent Notice of Award. Upward adjustments to awarded levels will be considered after FY 2024 appropriations are enacted.
When making funding decisions, NIDCR may consider other relevant factors such as, but not limited to, scores assigned during peer review, new scientific opportunities, current research priorities, portfolio balance, and alignment with the NIDCR Strategic Plan 2021-2026 and availability of funds.
Consistent with the NIH Next Generation Researchers Initiative, NIDCR is committed to support a robust and diverse workforce through additional funding consideration for supporting Early Stage Investigators (ESIs) and At-risk Investigators. All competing ESI non-modular applications will be reduced by 10 percent, and modular applications will not be affected.